Novo Nordisk A/S
Save
459.47B
Market cap
28.52x
Current P/E
27.10x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases.
Similar securities
Based on sector and market capitalization
Report issue